C-MER MEDICAL 03309·

Gross margin 32.20%--25.85%6.35%32.17%6.32%27.58%4.59%31.01%3.43% Net margin 1.46%---2.67%4.13%4.49%7.16%-5.66%10.15%5.71%11.37% ROE 1.64%---1.17%2.81%3.36%4.53%-7.71%11.07%5.65%13.37% ROA 0.83%---1.59%2.42%3.14%4.73%-3.98%7.12%4.07%8.05% Revenue growth ----70.07%--12.70%57.37%1.61%11.09%-0.75%2.37% Attributable profit growth -----209.33%--387.53%596.85%-322.78%710.31%172.43%495.21% Debt-to-assets 31.63%--31.14%0.49%27.48%3.65%30.52%3.04%29.13%1.39% Current ratio 1.83--1.630.201.850.221.560.291.430.13 Operating cash flow / net profit 8.90---3.5712.464.187.75-2.616.802.555.16 Operating cash flow / revenue 12.98%--9.52%3.46%18.77%9.25%14.80%3.97%14.55%0.25%

Gross margin 31.12%--31.56%0.44% Net margin 5.95%--5.57%0.38% Revenue growth ----8.48%-- Attributable profit growth ----0.15%-- Debt-to-assets ----30.33%-- Current ratio ----1.40-- Operating cash flow / net profit 1.93--3.831.91 Operating cash flow / revenue 11.45%--21.34%9.89%

Revenue 909.64M--1.55B70.07%1.74B12.70%1.77B1.61%1.76B0.75% Other income and gains 8.65M--25.60M195.90%7.62M70.21%8.21M7.69%9.35M13.94% Gross profit 292.89M--399.91M36.54%560.92M40.26%488.60M12.89%545.25M11.59% Selling and distribution expenses 103.38M--113.24M9.54%133.94M18.28%123.52M7.78%127.34M3.09% Administrative expenses 191.41M--308.49M61.16%321.64M4.26%317.25M1.37%298.42M5.94% Net finance costs 6.97M--17.56M152.06%16.42M6.47%21.91M33.41%21.99M0.36% Income tax 8.70M--31.26M259.20%34.38M9.96%29.72M13.55%40.05M34.77% Operating profit 20.23M---32.59M261.09%108.15M431.85%-61.27M156.65%151.26M346.89% Share of associates and JVs 8.71M--33.76M287.70%2.87M91.51%-902.89K131.49%-524.77K41.88% Profit before tax 21.97M---10.03M145.64%112.62M1222.92%-70.58M162.68%140.47M299.01% Net profit 13.27M---41.29M411.17%78.24M289.48%-100.30M228.20%100.41M200.11% Net profit attributable to owners 17.87M---19.54M209.33%56.18M387.53%-125.17M322.78%90.65M172.43%

Revenue 944.33M--1.02B8.48% Other income and gains 3.16M--6.08M92.37% Cost of sales 650.42M--701.07M7.79% Gross profit 293.90M--323.36M10.02% Selling and distribution expenses 63.49M--76.61M20.68% Administrative expenses 165.41M--162.16M1.96% Net finance costs 4.59M--5.68M23.61% Income tax 19.24M--23.96M24.55% Operating profit 81.26M--86.66M6.65% Share of associates and JVs -1.27M---3.00K99.76% Profit before tax 75.39M--80.98M7.41% Net profit 56.15M--57.02M1.54% Net profit attributable to owners 49.94M--50.02M0.15%

Cash and cash equivalents 316.13M--575.89M82.17%464.68M19.31%391.79M15.68%314.20M19.80% Trade and bills receivables 14.70M--42.10M186.40%48.37M14.88%53.49M10.60%59.33M10.92% Inventories 27.34M--45.89M67.84%35.21M23.29%43.75M24.27%46.13M5.44% Total current assets 610.25M--765.14M25.38%652.60M14.71%593.11M9.12%606.41M2.24% Total assets 1.60B--2.59B62.09%2.49B3.90%2.52B1.13%2.47B2.02% Total current liabilities 333.78M--468.79M40.45%352.81M24.74%379.70M7.62%423.06M11.42% Total liabilities 505.80M--807.02M59.56%684.51M15.18%768.84M12.32%718.97M6.49% Equity attributable to owners 1.09B--1.67B53.15%1.67B0.35%1.62B2.97%1.60B1.22% Total equity 1.09B--1.78B63.26%1.81B1.20%1.75B3.11%1.75B0.05%

Cash and cash equivalents ----543.63M-- Trade and bills receivables ----58.32M-- Inventories ----55.38M-- Total current assets ----747.91M-- Total assets ----2.86B-- Total current liabilities ----533.97M-- Total liabilities ----868.58M-- Equity attributable to owners ----1.83B-- Total equity ----2.00B--

Net cash from operating activities 118.06M--147.27M24.74%327.28M122.24%262.18M19.89%255.88M2.41% Net cash from investing activities -323.55M---174.81M45.97%-222.36M27.20%-161.80M27.24%-128.79M20.40% Net cash from financing activities 69.60M--262.33M276.94%-220.10M183.90%-180.50M17.99%-199.86M10.73% Net change in cash -135.89M--234.79M272.78%-115.18M149.05%-80.12M30.44%-72.77M9.16%

Net cash from operating activities 108.10M--218.60M102.22% Net cash from investing activities -46.10M--65.00M241.00% Net cash from financing activities -110.70M---94.00M15.09%